Improving drug discovery through parallelism

Jerónimo S. García1, Savíns Puertas-Martín2,1, Juana L. Redondo1, Juan José Moreno1, Pilar M. Ortigosa1
1Supercomputing - Algorithms Research Group (SAL), Agrifood Campus of International Excellence, University of Almería, Almería, Spain
2Information School, University of Sheffield, Sheffield, United Kingdom

Tóm tắt

Compound identification in ligand-based virtual screening is limited by two key issues: the quality and the time needed to obtain predictions. In this sense, we designed OptiPharm, an algorithm that obtained excellent results in improving the sequential methods in the literature. In this work, we go a step further and propose its parallelization. Specifically, we propose a two-layer parallelization. Firstly, an automation of the molecule distribution process between the available nodes in a cluster, and secondly, a parallelization of the internal methods (initialization, reproduction, selection and optimization). This new software, called pOptiPharm, aims to improve the quality of predictions and reduce experimentation time. As the results show, the performance of the proposed methods is good. It can find better solutions than the sequential OptiPharm, all while reducing its computation time almost proportionally to the number of processing units considered.

Từ khóa


Tài liệu tham khảo

Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63:457–460. https://doi.org/10.1007/s11427-020-1637-5 Sheinson DM, Wong WB, Solon CE, Cheng MM, Shah A, Elsea D, Meng Y (2021) Estimated impact of public and private sector Covid-19 diagnostics and treatments on us healthcare resource utilization. Adv Ther 38:1212–1226. https://doi.org/10.1007/s12325-020-01597-3 Hughes J, Rees S, Kalindjian S, Philpott K (2011) Principles of early drug discovery. Br. J. Pharmacol. 162(6):1239–1249. https://doi.org/10.1111/j.1476-5381.2010.01127.x Morgan S, Grootendorst P, Lexchin J, Cunningham C, Greyson D (2011) The cost of drug development: a systematic review. Health Policy 100:4–17. https://doi.org/10.1016/j.healthpol.2010.12.002 Wildey MJ, Haunso A, Tudor M, Webb M, Connick JH (2017) High-throughput screening. Annu Rep Med Chem. https://doi.org/10.1016/bs.armc.2017.08.004 Shen L, Niu J, Wang C, Huang B, Wang W, Zhu N, Deng Y, Wang H, Ye F, Cen S, Tan W (2019) High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J Virol. https://doi.org/10.1128/JVI.00023-19 Zeng W, Guo L, Xu S, Chen J, Zhou J (2020) High-throughput screening technology in industrial biotechnology. Trends Biotechnol 38:888–906. https://doi.org/10.1016/j.tibtech.2020.01.001 Fischer A, Sellner M, Neranjan S, Smieško M, Lill MA (2020) Potential inhibitors for novel coronavirus protease identified by virtual screening of 606 million compounds. Int J Mol Sci 21:3626. https://doi.org/10.3390/ijms21103626 Maia EHB, Assis LC, de Oliveira TA, da Silva AM, Taranto AG (2020) Structure-based virtual screening: from classical to artificial intelligence. Front Chem. https://doi.org/10.3389/fchem.2020.00343 Ripphausen P, Nisius B, Bajorath J (2011) State-of-the-art in ligand-based virtual screening. Drug Discov Today 16:372–376. https://doi.org/10.1016/j.drudis.2011.02.011 Glantz-Gashai Y, Meirson T, Reuveni E, Samson AO (2017) Virtual screening for potential inhibitors of mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance. Drug Des Dev Ther 11:1803–1813. https://doi.org/10.2147/DDDT.S133127 Lyne PD (2002) Structure-based virtual screening: an overview. Drug Discov Today 7:1047–1055. https://doi.org/10.1016/S1359-6446(02)02483-2 dos Santos RN, Ferreira LG, Andricopulo AD (2018) Practices in molecular docking and structure-based virtual. Screening. https://doi.org/10.1007/978-1-4939-7756-7_3 Puertas-Martín S, Redondo JL, Ortigosa PM, Pérez-Sánchez H (2019) OptiPharm: an evolutionary algorithm to compare shape similarity. Sci Rep 9(1):1398. https://doi.org/10.1038/s41598-018-37908-6 Puertas-Martín S, Redondo LJ, Pérez-Sánchez H, Ortigosa MP (2020) Optimizing electrostatic similarity for virtual screening: a new methodology. Informatica. https://doi.org/10.15388/20-INFOR424 Yan X, Li J, Liu Z, Zheng M, Ge H, Xu J (2013) Enhancing molecular shape comparison by weighted Gaussian functions. J Chem Inf Model 53(8):1967–1978. https://doi.org/10.1021/ci300601q Grant JA, Pickup BT (1995) A Gaussian description of molecular shape. J Phys Chem 99(11):3503–3510. https://doi.org/10.1021/j100011a016 Grant JA, Gallardo MA, Pickup BT (1996) A fast method of molecular shape comparison: a simple application of a Gaussian description of molecular shape. J Comput Chem 17(14):1653–1666 Wishart DS (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucl Acids Res 34(90001):668–672. https://doi.org/10.1093/nar/gkj067. arXiv:arXiv:1011.1669v3 Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucl Acids Res 46(D1):1074–1082. https://doi.org/10.1093/nar/gkx1037 Den-Haan H, José Hernández Morante J, Pérez-Sánchez H (2016) Computational evidence of a compound with nicotinic \(\alpha\)4\(\beta\)2-ach receptor partial agonist properties as possible coadjuvant for the treatment of obesity. bioRxiv. https://doi.org/10.1101/088138 OpenEye Scientific Software, Software, O.S., OpenEye Scientific Software: VIDA 4.4.0.4 (2019). www.eyesopen.com Ortigosa PM, García I, Jelásity M (2001) Reliability and performance of UEGO, a clustering-based global optimizer. J Glob Optim 19(3):265–289. https://doi.org/10.1023/A:1011224107143 Kalászi A, Szisz D, Imre G, Polgár T (2014) Screen3D: a novel fully flexible high-throughput shape-similarity search method. J Chem Inf Model 54(4):1036–1049. https://doi.org/10.1021/ci400620f Hu J, Liu Z, Yu DJ, Zhang Y (2018) LS-align: an atom-level, flexible ligand structural alignment algorithm for high-throughput virtual screening. Bioinformatics 34(13):2209–2218. https://doi.org/10.1093/bioinformatics/bty081 Ferraz WR, Gomes RA, S Novaes AL, Goulart Trossini GH (2020) Ligand and structure-based virtual screening applied to the sars-cov-2 main protease: an in silico repurposing study. Fut Med Chem 12(20):1815–1828. https://doi.org/10.4155/fmc-2020-0165 Fischer A, Sellner M, Neranjan S, Smieško M, Lill MA (2020) Potential inhibitors for novel coronavirus protease identified by virtual screening of 606 million compounds. Int J Mol Sci. https://doi.org/10.3390/ijms21103626 Banegas-Luna AJ, Cerón-Carrasco JP, Puertas-Martín S, Pérez-Sánchez H (2019) Bruselas: Hpc generic and customizable software architecture for 3d ligand-based virtual screening of large molecular databases. J Chem Inf Model 59:2805–2817. https://doi.org/10.1021/acs.jcim.9b00279